Form 4: Vaxart CFO Phillip E. Lee Reports Stock Transaction
SEC Form 4 Filing
Phillip E. Lee, CFO of Vaxart, Inc., reports the withholding of 2,007 common stock shares to cover income tax obligations related to vested RSUs.
Summary
- On June 12, 2024, Phillip E. Lee, the Chief Financial Officer of Vaxart, Inc. (VXRT), had 2,007 shares of common stock withheld by the issuer.
- This withholding was to satisfy income tax obligations related to the net settlement of Restricted Stock Units (RSUs) that vested on the same date.
- The price per share for the transaction was $0.76.
- Following the transaction, Lee directly owns 239,801 shares of Vaxart common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations on vested RSUs, and doesn't inherently indicate positive or negative sentiment. It's a neutral event.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests. This transaction reflects routine tax obligations related to equity compensation.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it involves the withholding of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of the stock transaction (tax withholding related to RSU vesting). |
| 06/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.